Purchase Order 75F40123P00174
Award Date
6/27/23
Potential Completion Date
6/26/24
Potential Value
$40K
Federal Agency
Food and Drug Administration
Awardee
Proquest LLC
Ultimate Awardee
Not listed
NAICS Category
519210 - Libraries and Archives
PSC Category
7630 - Newspapers And Periodicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Food and Drug Administration (FDA) was issued to ProQuest LLC, a foreign-owned, for-profit organization headquartered in Ann Arbor, Michigan. The $13,585 firm-fixed-price purchase order does not have a set-aside designation, indicating ProQuest competed as a large business. ProQuest is a critical vendor for federal agencies seeking comprehensive digital research and information services, with a robust presence in government procurement through extensive...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to ProQuest LLC for a ProQuest subscription. The contract has a ceiling value of $12,930.00 and an ultimate completion date of September 5, 2015. The contract is not set aside. ProQuest LLC is a foreign-owned, for-profit organization that provides subscription-based access to various databases and collections, including historical newspapers, legislative and regulatory insights, and other research...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed-price purchase order to The Pharma Letter LIMITED, a for-profit organization, for a $113,008.00 pharmaceutical subscription for 25 users. The contract has a performance period ending May 20, 2025, with an award date of May 20, 2020. The subscription provides the FDA's Office of Global Policy and Strategy (OGPS) staff with access to global news, expert commentary, and analysis on pharmaceutical, generic,...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $959,700 firm fixed price delivery order contract to Label Insight, Inc. for food and cosmetic database support and services. The one-year contract, with a period of performance from August 11, 2020 to September 29, 2021, will provide Label Insight's database solutions to support HHS FDA programs in Silver Spring, Maryland. No subcontractors or set aside designations were identified. This order for...
The Department of Health and Human Services Food and Drug Administration (HHS/FDA) awarded a $131,950 firm-fixed price purchase order to Informa Business Intelligence, Inc., a foreign-owned for-profit organization, to provide market share reports and a database platform. The award does not have a small business set-aside designation. The contract provides the FDA with data and information across the entire medical device industry, including market share, sales volume, emerging products,...
The Department of Health and Human Services Food and Drug Administration (FDA) awarded a firm fixed price purchase order to Source Healthcare Analytics LLC, a global provider of outsourced development services to the pharmaceutical and medical device industries. The $140,032 contract is for access to prescription and non-retail sales data by geography, to support the FDA's monitoring of drug safety and effectiveness during the national health emergency. This award is associated with a larger $45...
This $227,480 firm fixed price purchase order was awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Clarivate Analytics (Us) LLC, a global provider of scientific research databases and analytics platforms. The contract is for data acquisition services related to active pharmaceutical ingredient (API) manufacturing, with a completion date of September 24, 2023. Clarivate Analytics, a foreign-owned for-profit company, has held multiple indefinite...
This is a $180,000 firm fixed price purchase order awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Clarivate Analytics (Us) LLC, a global provider of scientific and medical research databases and analytics tools. The contract is for data acquisition services related to active pharmaceutical ingredients (APIs), including information on API manufacturing facilities and activities. This single-award contract has a completion date of September 24, 2021....
The Department of Health and Human Services Food and Drug Administration awarded a $207,623 purchase order to Clarivate Analytics (Us) LLC for ACTIVE PHARMACEUTICAL INGREDIENTS (API) MANUFACTURER DATA ACQUISITION. Under this firm fixed price contract, Clarivate Analytics will provide data acquisition services to the FDA relating to API manufacturers. Performance will take place in Silver Spring, Maryland over approximately one year, from September 2023 through September 2024. As the regulator of...
The Department of Health and Human Services Food and Drug Administration awarded a $4.8 million firm fixed price delivery order to Dun & Bradstreet Inc., doing business as D&B, for core services. The one-year contract will provide products and services to support HHS/FDA programs from D&B's offices in Herndon, Virginia. As one of the largest federal civilian agencies, HHS/FDA relies on data and analytical tools from major database and research firms under the Solutions for...